Aetiology and Antimicrobial Susceptibility Patterns of Lower Respiratory Tract Infections (LRTI’s) in a Rural Tertiary Care Teaching Hospital at Karimnagar, South India

K V Ramana^1, , Anand Kalaskar¹, Mohan Rao¹ and Sanjeev D Rao¹

¹Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Andhrapradesh, India

Cite this paper:
K V Ramana, Anand Kalaskar, Mohan Rao and Sanjeev D Rao. Aetiology and Antimicrobial Susceptibility Patterns of Lower Respiratory Tract Infections (LRTI’s) in a Rural Tertiary Care Teaching Hospital at Karimnagar, South India. American Journal of Infectious Diseases and Microbiology. 2013; 1(5):101-105. doi: 10.12691/ajidm-1-5-5

Abstract

Lower respiratory tract infections (LRTI’s) are amongst the most common causes of morbidity and mortality arising from infectious diseases both in the developed and developing nations. Prompt clinical and laboratory diagnosis along with appropriate treatment strategies would be helpful in the management of both community and nosocomially acquired LRTI’s. Our study was aimed at evaluating the aetiology and antimicrobial susceptibility patterns of LRTI’s in a tertiary care teaching hospital in south India. The results of the current study revealed that among the samples tested 56 (52.83%) were positive for various bacteria, 6 (5.6%) were showing the growth of fungi and 44 (41.5%) were revealing no pathogens. Klebsiella pneumoniae (45.1%) was the predominant gram negative bacterial pathogen isolated followed by Citrobacter freundii (12.9%), Pseudomonas aeruginosa (9.6%), and Staphylococcus aureus (9.6%) was the significant gram positive bacterial pathogen followed by Streptococcus pneumoniae (5.6%). The antimicrobial susceptibility pattern of the isolated bacteria indicated the presence of multidrug resistance, the production of Extended spectrum beta lactamases (ESBL) (75%) and metallo-betalactamases/carbapenemases (MBL) (25%) among gram negative bacterial isolates and MRSA (16.6%) and VRSA (16%) among the gram positive bacterial isolates. With varied geographical prevalence, and different antimicrobial susceptibility patterns, it becomes imperative to regularly evaluate the aetiology and antibiotic profiles of LRTI’s and formulate regional guidelines that guide clinical, laboratory diagnosis and management of patients suffering from LRTI’s.

Keywords:
Keywords: lower respiratory tract infections (LRTI’s) aetiology of LRTI’s antimicrobial susceptibility patterns patient management

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	M. Woodhead, F. Blasi ,S.Ewig, G. Huchon, M. Ieven, T. Schaberg, A. Torres, G. van der Heijden, A. Ortqvist and T.J.M. Verhlj. Guidelines for the management of adult lower respiratory tract infections Eur Respir J 2005; 26: 1138-1180.
[2]	Bharat Bhushan Sharma and Virendra singh. Indian Pneumonia guidelines. Lung India 2012; 29 (4): 307-308.
[3]	Anne B Chang, Christina C Chang, K O Grady, P J Torzillo. Lower respiratory tract infections. Pediatr Clin N Am 2009; 56: 1303-1321.
[4]	Boloursaz MR, Lotfian F, Aghahosseini F, Cheraghvandi A, Khalilzadeh S, Farjah A, Boloursaz M. Epidemiology of Lower Respiratory Tract Infections in Children. J Compr Ped. 2013; 3(3): 93-8.
[5]	World Health Organization. Disease and injury country estimates. Accessed from WHO website on 12th September, 2013: http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html.
[6]	Sheldon Campbell and Betty a Forbes. The Clinical Microbiology Laboratory in the Diagnosis of Lower Respiratory Tract Infections. J Clin Microbiol 2011; 49(9 supplement): S30.
[7]	Reimer LG, Carroll KC, Role of the Microbiology Laboratory in the Diagnosis of Lower Respiratory Tract Infections, Clin Infect Dis 1998; 26:743-748.
[8]	Karen C Carroll. Laboratory Diagnosis of Lower Respiratory Tract Infections: Controversy and Conundrums. J Clin Microbiol 2002; 40(9): 3115-3120.
[9]	Beck JM, Young VB, Huffnagle GB: The microbiome of the lung. Transl Res 2012, 160(4):258-266.
[10]	Brookes-Howell L, Hood K, Cooper L, et al. Clinical influences on antibiotic prescribing decisions for lower respiratory tract infection: a nine country qualitative study of variation in care. BMJ Open 2012; 2:e000795.
[11]	Whaley et al.: Visit complexity, diagnostic uncertainty, and antibiotic prescribing for acute cough in primary care: a retrospective study. BMC Family Practice 2013; 14:120.
[12]	King et al.: Bacteria in COPD; their potential role and treatment. Translational Respiratory Medicine 2013; 1:13.
[13]	Collee JG, Miles RS, Watt B. Tests for identification of bacteria. In Collee JG, Fraser AG, Marmion BP, Simmons A. eds. Mackie and McCartney's Practical medical microbiology, 14th ed. Churchill Livingstone, 2006.
[14]	Clinical Laboratory Standards Institute (CLSI) Guidelines. Performance Standards for Antimicrobials Disk Susceptibility Tests. Approved standard. 11 Th ed. CLSI document M100-S22. Wayne, PA: CLSI; 2012.
[15]	Winn WC, Allen S, Janda WM, Koneman EW, Schreckenberger PC, Procop G, Baker Woods G., In: Koneman's Color Atlas and Textbook of Diagnostic Micryobiology, 6th ed. Williams and Wilkins, Lippincott.
[16]	Centers for Disease Control and Prevention (CDC) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009; 58:256-60.
[17]	Christopher Aye Egbe, Casimir Ndiokwere, Richard Omoregie. Microbiology of lower respiratory tract infections in Benin city, Nigeria. Malaysian J Med Sci 2011; 18 (2): 27-31.
[18]	Mishra SK, Kattel HP, Acharya J, et al. Recent trend of bacterial aetiology of lower respiratory tract infections in a tertiary care centre of Nepal. Int J Infect Microbiol 2012; 1(1):3-8.
[19]	Yuhua Zhou, Ping Lin, Qingtian Li, Lizhong Han, Huajun Zheng, Yanxia Wei, Zelin Cui and Xiaokui Guo. Analysis of the microbiota of sputum samples from patients with lower respiratory tract infections. Acta Biochim Biophys Sin 2010; 42(10): 754-761.
[20]	Kim M Hare, Heidi C Smith-Vaughan, Amanda J Leach. The bacteriology of lower respiratory infections in Papua New Guinean and Australian Indigenous children. PNG Med J 2010; 53 (3-4): 151-165.
[21]	Supriya Panda, B. Prema Nandini, T.V.Ramani. Lower respiratory tract infections-Bacteriological profile and antibiogram pattern. Int J Cur Res Rev 2012; 4(21): 149-155.
[22]	Giovanni Battista Migliori, Miranda W. Langendam, Lia D’Ambrosio, Rosella Centis, Francesco Blasi Marieke J. van der Werf, Emma Huitric, Davide Manissero. Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J 2012;40: 814-822.
[23]	Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, a randomised placebo-controlled trial. The Lancet Infectious Diseases 2012; 13(2): 123-129.
[24]	Borradale D (2013-03-14 00:01:17). Combating the rise of the superbugs: The health and scientific challenges of antibiotic resistance. Australian Science. Retrieved: Sep 08, 2013, from http://www.australianscience.com.au/biology/combating-the-rise-of-the-superbugs-the-health-and-scientific-challenges-of-antibiotic-resistance/.
[25]	OL Moncayo-Nieto, P Reid, IF Laurenson, AJ Simpson. Improving the use of sputum cultures in lower respiratory tract infection. J R Coll Physcians Edinb 2013; 43: 108-13.
[26]	Beena Philomina J. Role of respiratory samples in the diagnosis of lower respiratory tract infections. Pulmon 2009; 11: 1: 12-14.